Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
ReposiTrak
TRAK
$159M
| $1.03M | ﹤0.01% |
83,373
+36,832
| +79% | +$523K |
|
5052
Forrester Research
FORR
$200M
| $1.03M | ﹤0.01% |
126,895
-67,008
| -35% | -$526K |
|
5053
Moog Inc Class B
MOG.B
$13.6B
| $1.03M | ﹤0.01% |
4,140
+3,912
| +1,716% | +$919K |
|
|
REFA
5054
Columbia Research Enhanced International Equity ETF
REFA
$6.82M
| $1.03M | ﹤0.01% |
+50,000
| New | +$1.02M |
|
|
NVA
5055
Nova Minerals Corp
NVA
$175M
| $1.02M | ﹤0.01% |
167,716
+36,041
| +27% | +$281K |
|
5056
M-tron Industries
MPTI
$355M
| $1.02M | ﹤0.01% |
19,228
-3,307
| -15% | -$175K |
|
|
AARD
5057
Aardvark Therapeutics
AARD
$140M
| $1.02M | ﹤0.01% |
77,954
+9,492
| +14% | +$118K |
|
5058
ARKO Corp
ARKO
$901M
| $1.02M | ﹤0.01% |
225,129
+57,062
| +34% | +$256K |
|
|
ALMU
5059
Aeluma Inc
ALMU
$260M
| $1.02M | ﹤0.01% |
59,383
+13,625
| +30% | +$215K |
|
5060
ProFrac Holding
ACDC
$671M
| $1.02M | ﹤0.01% |
261,973
-44,470
| -15% | -$182K |
|
5061
Travelzoo
TZOO
$77.8M
| $1.02M | ﹤0.01% |
142,731
+6,266
| +5% | +$50.7K |
|
5062
Compañía de Cervecerías Unidas
CCU
$2.2B
| $1.01M | ﹤0.01% |
79,331
-8,249
| -9% | -$104K |
|
|
MUNB
5063
Northern Trust 2035 Tax-Exempt Distributing Ladder ETF
MUNB
$10M
| $1.01M | ﹤0.01% |
10,000
| – | – |
|
5064
Future Fuel
FF
$202M
| $1.01M | ﹤0.01% |
316,506
-34,233
| -10% | -$123K |
|
5065
Domo
DOMO
$170M
| $1.01M | ﹤0.01% |
119,722
-204,495
| -63% | -$2.4M |
|
5066
Lifeway Foods
LWAY
$470M
| $1.01M | ﹤0.01% |
41,518
-12,189
| -23% | -$299K |
|
5067
VanEck Retail ETF
RTH
$254M
| $1M | ﹤0.01% |
4,024
-54
| -1% | -$13.5K |
|
5068
Vista Gold
VGZ
$245M
| $1M | ﹤0.01% |
509,508
+269,509
| +112% | +$520K |
|
|
CXE
5069
DELISTED
MFS High Income Municipal Trust
CXE
| $1,000K | ﹤0.01% |
270,203
+2,913
| +1% | +$10.8K |
|
5070
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$538M
| $992K | ﹤0.01% |
6,222
-36,667
| -85% | -$5.03M |
|
5071
ProShares Hedge Replication ETF
HDG
$21.9M
| $984K | ﹤0.01% |
19,087
-2,578
| -12% | -$133K |
|
5072
Aspen Aerogels
ASPN
$364M
| $984K | ﹤0.01% |
347,648
-346,840
| -50% | -$1.79M |
|
5073
Instil Bio
TIL
$49.4M
| $979K | ﹤0.01% |
88,979
-13,959
| -14% | -$207K |
|
5074
Star Group
SGU
$415M
| $978K | ﹤0.01% |
82,559
-34,128
| -29% | -$404K |
|
5075
Prelude Therapeutics
PRLD
$370M
| $971K | ﹤0.01% |
334,916
+50,713
| +18% | +$85.6K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.